Balversa 4 MG tablet 56S
Ended Awarded
- Contract number
- SPE2DR26FQQ2D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,118
Award facts
- Contract value 100% obligated
- $25,117.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,117.51 to AmerisourceBergen Drug Corp for the supply of Balversa 4 mg tablets (56-count units) on November 17, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is well-positioned to fulfill this requirement as a primary supplier within the DLA's medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026. This comprehensive prime IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal government healthcare systems worldwide. The contract structure demonstrates the contractor's established capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains on a competitive basis.
Quick answers
Who was awarded contract SPE2DR26FQQ2D?
SPE2DR26FQQ2D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FQQ2D worth?
The government has obligated $25,118 on SPE2DR26FQQ2D.
Is contract SPE2DR26FQQ2D an order under another contract?
Yes. SPE2DR26FQQ2D is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ2D competed?
The extent of competition for SPE2DR26FQQ2D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award